Stay updated on Pembrolizumab in Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Pancreatic Cancer Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The screenshots show essentially the same study details page with no substantial edits to core content such as eligibility criteria, interventions, or outcomes; only minor UI/formatting differences. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T21:13:59.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    29 days ago
    Change Detected
    Summary
    Added a government-funding notice and updated the version to v3.2.0, while removing the old v3.1.0 version tag.
    Difference
    5%
    Check dated 2025-10-06T05:41:01.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    Updated to Revision: v3.1.0 with expanded contact emails/phone numbers; removed obsolete revision v3.0.2. No changes detected to pricing, stock, or time slots.
    Difference
    0.1%
    Check dated 2025-09-29T03:08:04.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    Updated Revision from v3.0.1 to v3.0.2; removed the 'Back to Top' element. No other substantive changes detected.
    Difference
    0.3%
    Check dated 2025-09-14T19:18:11.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.3%
    Check dated 2025-09-07T15:49:52.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location, as well as new content related to Combined Modality Therapy and Neoadjuvant Therapy. Notably, the drug pembrolizumab has been both added and removed, indicating a potential update in its relevance or context.
    Difference
    3%
    Check dated 2025-08-31T11:57:44.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Pancreatic Cancer Clinical Trial page.